I am board-certified in internal medicine and preventive and occupational medicine and an epidemiologist. I am the past Editor in Chief of the International Journal of Occupational and Environmental Health and current Editor of the The Journal of Scientific Practice and Integrity. I have a broad range of interests including research misconduct and the marketing of toxic pharmaceuticals, silicone implants, radiation exposure, asbestos exposure and health (NOT just health care) in under-developing countries. I also research the history of the development of knowledge of warnings and health effects and the epistemology of scientific knowledge.
My work as an expert witness has uncovered many different types of corporate and government malfeasance. I have vigorously fought for the release of sealed company documents uncovered during litigation. For example, I sought to unseal documents pertaining to the serious harm produced by Merck’s painkiller, Vioxx, and Eli Lilly’s neuroleptic drug, Zyprexa and Oxycontin; whose manufacturers concealed and misrepresented risks known to them from the public and regulatory agencies.
I have testified before the House Subcommittee on Energy and Commerce, the President’s Advisory Committee on Human Radiation Experiments, and FDA advisory committees.
I am President of the Board, Global Health Through Education Training and Service, a non-profit that funds women's health and COPC medical school curriculum development in under developing countries in Africa, Asia and Latin America.
Egilman, David, Steffen, Joan. "Commentary on “Assessment of Health Risk From Historical Use of Cosmetic Talcum Powder”." NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, 2018, pp. 104829111879416. |
Steffen JE, Fassler EA, Reardon KJ, Egilman DS. "Grave fraudulence in medical device research: a narrative review of the PIN seeding study for the Pinnacle hip system." Accountability in research, vol. 25, no. 1, 2018, pp. 37-66. |
Egilman DS, Steffen JE, Fassler EA, Reardon KJ. "Letter to the editor on " Survivorship of a modular acetabular cup system: medium- to long-term follow-up"." Arthroplasty today, vol. 4, no. 3, 2018, pp. 392-393. |
Egilman, David. "The Production of Corporate Research to Manufacture Doubt About the Health Hazards of Products: An Overview of the Exponent Bakelite® Simulation Study." NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, 2018, pp. 104829111876548. |
Egilman, David, Bird, Tess, Wilson, Remi. "Use of Anti-Warnings to Falsely Reassure Downstream Users: An Asbestos Example." NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, 2018, pp. 104829111879419. |
Egilman, David, Bird, Tess, Wilson, Remi. "Use of Anti-Warnings to Falsely Reassure Downstream Users: An Asbestos Example." NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, 2018, pp. 104829111879419. |
Baur X, Woitowitz HJ, Budnik LT, Egilman D, Oliver C, Frank A, Soskolne CL, Landrigan PJ, Lemen RA. "Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update." American Journal of Industrial Medicine, vol. 60, no. 5, 2017, pp. 411-421. |
Egilman, David, Monárrez, Rubén. "Corporate corruption of science-Another asbestos example." American Journal of Industrial Medicine, vol. 60, no. 2, 2017, pp. 152-162. |
Egilman, David, Monárrez, Rubén. "Corporate corruption of science-Another asbestos example." American Journal of Industrial Medicine, vol. 60, no. 2, 2017, pp. 152-162. |
Oliver, L. Christine, Belpoggi, Fiorella, Budnik, Lygia T., Egilman, David, Frank, Arthur L., Mandrioli, Daniele, Soskolne, Colin L., Terracini, Benedetto, Welch, Laura, Baur, Xaver. "Correspondence regarding the article “The asbestos fibre burden in human lungs: new insights into the chrysotile debate”." European Respiratory Journal, vol. 50, no. 6, 2017, pp. 1701644. |
Egilman, David. "Response to Hessel." American Journal of Industrial Medicine, vol. 60, no. 10, 2017, pp. 915-920. |
Egilman D, Tran T. "A commentary on Roggli's "The So-Called Short-Fiber Controversy"." International Journal of Occupational and Environmental Health, vol. 22, no. 3, 2016, pp. 181-186. |
Egilman D, Bird T. "Short fiber tremolite free chrysotile mesothelioma cohort revealed." Am. J. Ind. Med., vol. 59, no. 3, 2016, pp. 196-199. |
Egilman D, Baur X, Soskolne CL. "Unreliable proposed 'new standard' for assessing asbestos exposure." Occupational and environmental medicine, vol. 73, no. 10, 2016, pp. 709. |
Baur X, Budnik LT, Ruff K, Egilman DS, Lemen RA, Soskolne CL. "Ethics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public health." International Journal of Occupational and Environmental Health, vol. 21, no. 2, 2015, pp. 172-5. |
Egilman D, Bird T, Lee C. "Dust diseases and the legacy of corporate manipulation of science and law." International Journal of Occupational and Environmental Health, vol. 20, no. 2, 2014, pp. 115-25. |
Egilman D, Schilling JH. "Egilman and Schilling respond." International Journal of Occupational and Environmental Health, vol. 20, no. 1, 2014, pp. 6-8. |
Egilman DS. "Workers and consumers should not be exposed to chemicals that have not been tested for toxicity." American Journal of Industrial Medicine, vol. 57, no. 8, 2014, pp. 970-1. |
Egilman DS, Druar NM. "Commentary on 'evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature', Donovan et al.1." International Journal of Occupational and Environmental Health, vol. 19, no. 3, 2013, pp. 163-8. |
Egilman DS, Bird T, Lee C. "MetLife and its corporate allies: dust diseases and the manipulation of science." International Journal of Occupational and Environmental Health, vol. 19, no. 4, 2013, pp. 287-303. |
Aguilar Madrid G, Beaudry M, Bell W, Bowes D, Brophy J, Burdorf A, Carlsten C, Castleman B, Chaturvedi S, Conti ME, Corra L, Corrêa Filho HR, Cranor CF, Cullen E, Dalvie A, Dickson RC, Digon A, Egilman D, Eisner Falvo C, Fischer E, Frank AL, Frank E, Gee D, Giannasi F, Goldstein BD, Greenberg M, Guidotti TL, Harris WA, Hindry M, Houlson A, Hu H, Huff J, Infante PF, Thambyappa J, Juarez Perez CA, Jeebhay MF, Joshi TK, Keith M, Keyserlingk JR, Khatter K, King D, Kodeih N, Kristensen J, Kulsomboon V, Landrigan PJ, Lee CW, Leigh J, Lemen RA, Lippman A, London L, Matzopoulos R, McCulloch J, McDiarmid MA, Mehrdad R, Mirabelli D, Moshammer H, Notebaert É, Nycz Z, Oberta AF, O'Connor J, O'Neill R, Orris P, Ozonoff D, Paek D, Rickard C, Rodriguez EJ, Sass J, Sentes KE, Simpson IM, Soffritti M, Soskolne CL, Sparling SP, Spiegel J, Takahashi K, Takaro TK, Terracini B, Thébaud-Mony A, Trosic I, Turcotte F, Vakil C, Van Der Walt A, Waterman YR, Watterson A, Wegman DH, Welch LS, Weiss SH, Winston R, Yassi A. "Statement in response to asbestos industry efforts to prevent a ban on asbestos in Pakistan: chrysotile asbestos use is not safe and must be banned." Archives of environmental & occupational health, vol. 68, no. 4, 2013, pp. 243-9. |
Egilman DS. "The importance of scientific debate." International Journal of Occupational and Environmental Health, vol. 19, no. 3, 2013, pp. 157-9. |
Egilman DS, Schilling JH. "Bronchiolitis obliterans and consumer exposure to butter-flavored microwave popcorn: a case series." International Journal of Occupational and Environmental Health, vol. 18, no. 1, 2012, pp. 29-42. |
Egilman D, Schilling JH. "Letter to the Editor regarding the Donovan et al. (2011) article." Critical reviews in toxicology, vol. 42, no. 2, 2012, pp. 169-72; author reply 173-83. |
Egilman D. "Report of a recent "brake" through in the fiber burden-mesothelioma dialogue." Inhalation toxicology, vol. 24, no. 2, 2012, pp. 136-7. |
Egilman D, Druar NM. "Spin your science into gold: direct to consumer marketing within social media platforms." Work (Reading, Mass.), vol. 41 Suppl 1, 2012, pp. 4494-502. |
De Maeseneer J, Roberts RG, Demarzo M, Heath I, Sewankambo N, Kidd MR, van Weel C, Egilman D, Boelen C, Willems S. "Tackling NCDs: a different approach is needed." The Lancet, vol. 379, no. 9829, 2012, pp. 1860-1. |
Egilman D, Menéndez LM. "A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec, Canada: A black swan case." American Journal of Industrial Medicine, vol. 54, no. 2, 2011, pp. 153-6. |
Egilman DS, Schilling JH, Menendez L. "A proposal for a safe exposure level for diacetyl." International Journal of Occupational and Environmental Health, vol. 17, no. 2, 2011, pp. 122-34. |
Egilman D. "An elaboration of "proof" of peritoneal mesothelioma from tremolite free chrysotile." American Journal of Industrial Medicine, vol. 54, no. 8, 2011, pp. 647. |
Egilman DS, Druar NM. "Corporate versus public interests: community responsibility to defend scientific integrity." International Journal of Occupational and Environmental Health, vol. 17, no. 2, 2011, pp. 181-5. |
Egilman DS, Ardolino EL, Howe S, Bird T. "Deconstructing a state-of-the-art review of the asbestos brake industry." NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, vol. 21, no. 4, 2011, pp. 545-71. |
Egilman D, Bird T, Mora F, Druar N. "Gets AIDS and survive? The "perverse" effects of aid: addressing the social and environmental determinants of health, promoting sustainable primary care, and rethinking global health aid." International Journal of Occupational and Environmental Health, vol. 17, no. 4, 2011, pp. 364-82. |
De Maeseneer J, Egilman D, Burdick WP, Kaufman A. "Medical schools in sub-Saharan Africa." The Lancet, vol. 378, no. 9799, 2011, pp. 1294; author reply 1295. |
Krumholz SD, Egilman DS, Ross JS. "Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial." Arch Intern Med, vol. 171, no. 12, 2011, pp. 1100-7. |
Ross JS, Madigan D, Konstam MA, Egilman DS, Krumholz HM. "Persistence of cardiovascular risk after rofecoxib discontinuation." Arch Intern Med, vol. 170, no. 22, 2010, pp. 2035-6. |
Takaro TK, Davis D, Van Rensburg SJ, Arroyo Aguilar RS, Algranti E, Bailar JC 3rd, Belpoggi F, Berlin M, Bhattacharya S, Bonnier Viger YV, Brophy J, Bustinza R, Cameron RB, Dement JM, Egilman D, Castleman B, Chaturvedi S, Cherniack M, Choudhury H, Demers PA, Digangi J, Digon A, Edwards JG, Englund A, Erikson B, Corréa Filho HR, Franco G, Frank AL, Freund A, Gee D, Giordano A, Gochfeld M, Gilberg M, Goldsmith DF, Goldstein BD, Grandjean P, Greenberg M, Gut I, Harari R, Hindry M, Hogstedt C, Huff J, Infante PF, Järvholm B, Kern DG, Keifer M, Khatter K, Kjuus H, Keith M, Koo LC, Kumar A, LaDou J, Landrigan PJ, Lemen RA, Last JM, Lee CW, Leigh J, Levin SM, Lippman A, Madrid GA, McCulloch J, McDiarmid MA, Merchant JA, Monforton C, Morse T, Muir DC, Mukerjee D, Mulloy KB, Myers J, Nuwayhid I, Orris P, Ozonoff D, Paek D, Patra M, Pelclová D, Pepper L, Poje GV, Rahman Q, Reyes B, Robinson BW, Rodríguez E, Rose C, Rosenman KD, Rosenstock L, Ruchirawat M, Rydzyński K, Schneider J, Silverstein B, Siqueira CE, Slatin C, Soffritti M, Soskoline C, Sparer J, Stayner LT, Takaro TK, Tarkowski S, Teitelbaum DT, Tompa A, Trosic I, Turcotte F, Vilela RA, Waterman YR, Watterson A, Wegman DH, Welch LS, Woitowitz HJ, Yanri Z, Zavariz C. "Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing world." International Journal of Occupational and Environmental Health, vol. 16, no. 2, 2010, pp. 241-8. |
Egilman DS, Bohme S. "Small is not necessarily beautiful." International Journal of Occupational and Environmental Health, vol. 16, no. 4, 2010, pp. 542-3. |
Swanson RC, Mosley H, Sanders D, Egilman D, De Maeseneer J, Chowdhury M, Lanata CF, Dearden K, Bryant M. "Call for global health-systems impact assessments." The Lancet, vol. 374, no. 9688, 2009, pp. 433-5. |
Egilman D. "Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony." International Journal of Occupational and Environmental Health, vol. 15, no. 2, 2009, pp. 202-28. |
Egilman D. "Ford, General Motors, Chrysler, asbestos, and a "sane appreciation of the risks"." International Journal of Occupational and Environmental Health, vol. 15, no. 1, 2009, pp. 109-10. |
Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM. "Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance." Arch Intern Med, vol. 169, no. 21, 2009, pp. 1976-85. |
Bohme SR, Egilman D. "Beyond reputation: debate on the role of corporate influence in occupational and environmental medicine." NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy, vol. 18, no. 3, 2008, pp. 317-24. |
De Maeseneer J, van Weel C, Egilman D, Mfenyana K, Kaufman A, Sewankambo N, Flinkenflögel M. "Funding for primary health care in developing countries." BMJ, vol. 336, no. 7643, 2008, pp. 518-9. |
Ross JS, Hill KP, Egilman DS, Krumholz HM. "Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation." JAMA, vol. 299, no. 15, 2008, pp. 1800-12. |
Egilman DS, Bohme SR. "IJOEH and the critique of bias." International Journal of Occupational and Environmental Health, vol. 14, no. 2, 2008, pp. 147-51. |
De Maeseneer J, van Weel C, Egilman D, Mfenyana K, Kaufman A, Sewankambo N. "Strengthening primary care: addressing the disparity between vertical and horizontal investment." The British journal of general practice : the journal of the Royal College of General Practitioners, vol. 58, no. 546, 2008, pp. 3-4. |
Hill KP, Ross JS, Egilman DS, Krumholz HM. "The ADVANTAGE seeding trial: a review of internal documents." Annals of Internal Medicine, vol. 149, no. 4, 2008, pp. 251-8. |
Egilman D, Howe S. "Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology." International Journal of Occupational and Environmental Health, vol. 13, no. 1, 2007, pp. 118-24. |
LaDou J, Teitelbaum DT, Egilman DS, Frank AL, Kramer SN, Huff J. "American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry." International Journal of Occupational and Environmental Health, vol. 13, no. 4, 2007, pp. 404-26. |
Egilman DS, Presler AH, Valentin CS. "Avoiding the regulatory capture of the Food and Drug Administration." Arch Intern Med, vol. 167, no. 7, 2007, pp. 732-3. |
Abdo KM, Camargo CA Jr, Davis D, Egilman D, Epstein SS, Froines J, Hattis D, Hooper K, Huff J, Infante PF, Jacobson MF, Teitelbaum DT, Tickner JA. "Letter to U.S. FDA commissioner. Questions about the safety of the artificial sweetener aspartame." International Journal of Occupational and Environmental Health, vol. 13, no. 4, 2007, pp. 449-50. |
Egilman D, Scout, Kol L, Hegg LA, Bohme SR. "Manipulated data in Shell's Benzene Historical Exposure Study." International Journal of Occupational and Environmental Health, vol. 13, no. 2, 2007, pp. 222-32. |
Egilman D, Mailloux C, Valentin C. "Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy." International Journal of Occupational and Environmental Health, vol. 13, no. 1, 2007, pp. 85-98. |
Krumholz HM, Ross JS, Presler AH, Egilman DS. "What have we learnt from Vioxx?." BMJ, vol. 334, no. 7585, 2007, pp. 120-3. |
Egilman D, Scout. "Corporate corruption of science--the case of chromium(VI)." International Journal of Occupational and Environmental Health, vol. 12, no. 2, 2006, pp. 169-76. |
Egilman DS, Billings MA. "Differential peeky bias." International Journal of Occupational and Environmental Health, vol. 12, no. 3, 2006, pp. 294. |
Bailar JC 3rd, Ballal SG, Boback M, Castleman B, Chee HL, Cherniack M, Christiani D, Cicolella A, Fernández de D'Pool J, Egilman D, Frank AL, Garcia MA, Giannasi F, Greenberg M, Harrison RJ, Huff J, Infante P, de Souza EJ, Joshi TK, Kamuzora P, Kazan-Allen L, Kern DG, Kromhout H, Kuswadji S, LaDou J, Lemen RA, Levenstein C, Luethje B, Mancini F, Meel BL, Mekonnen Y, Mendes R, Murie F, Myers J, O'Neill R, Osaro E, Paek D, Richter E, Robertson E, Samuels SW, Soskolne CL, Stuckey R, Teitelbaum DT, Terracini B, Thébaud-Mony A, Vanhoorne M, Wang X, Watterson A, Wedeen R. "FIOH-sponsored newsletter misrepresents asbestos hazards in Zimbabwe." International Journal of Occupational and Environmental Health, vol. 12, no. 3, 2006, pp. 254-8. |
Egilman DS, Presler AH. "Report of specific cardiovascular outcomes of the ADVANTAGE trial." Annals of Internal Medicine, vol. 144, no. 10, 2006, pp. 781. |
Egilman DS, Billings MA. "Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability." International Journal of Occupational and Environmental Health, vol. 11, no. 4, 2005, pp. 360-71. |
Egilman DS, Bohme SR. "Chevron-Texaco's science." International Journal of Occupational and Environmental Health, vol. 11, no. 4, 2005, pp. 456-7. |
Bohme SR, Zorabedian J, Egilman DS. "Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation." International Journal of Occupational and Environmental Health, vol. 11, no. 4, 2005, pp. 338-48. |
Egilman DS, Bohme SR. "Over a barrel: corporate corruption of science and its effects on workers and the environment." International Journal of Occupational and Environmental Health, vol. 11, no. 4, 2005, pp. 331-7. |
Egilman DS. "Suppression bias at the Journal of Occupational and Environmental Medicine." International Journal of Occupational and Environmental Health, vol. 11, no. 2, 2005, pp. 202-4. |
Breilh J, Branco Jefer C, Castelman BI, Cherniack M, Christiani DC, Cicolella A, Cifuentes E, Clapp R, Cole DC, Corn M, De Ben S, Diaz R, Egilman D, Finkelstein Y, Franco G, Frank AL, Friedman L, Gassert TH, Gochfeld M, Greenberg M, Hansen ES, Hay A, Hogstedt C, Huff J, Joshi TK, Kriebel D, Laborde A, LaDou J, Levenstein C, Levin SM, Loewenson R, Mikheev M, Montenegro R, Naidoo R, Ozonoff D, Partanen T, Pendito RI, Povey G, Richter ED, Robbins A, Rodrigues Corrèa Filho H, Rosenman KD, Samuels SW, Sousa SV, Schwartz BS, Siqueira CE, Soskolne CL, Spiegel J, Stephens C, Mansoureh T, Takaro TK, Teitelbaum DT, Tickner JA, Tomatis L, Victora C, Waltner-Toews D, Wedeen RP, Wegman DH, Wesseling C, Wing S, Yassi A. "Texaco and its consultants." International Journal of Occupational and Environmental Health, vol. 11, no. 2, 2005, pp. 217-20. |
Egilman D, Rankin Bohme S. "Attorney-directed screenings can be hazardous." American Journal of Industrial Medicine, vol. 45, no. 3, 2004, pp. 305-7. |
Egilman D, Tweedale G, McCulloch J, Kovarik W, Castleman B, Longo W, Levin S, Bohme SR. "P.W.J. Bartrip's attack on Irving J. Selikoff." American Journal of Industrial Medicine, vol. 46, no. 2, 2004, pp. 151-5. |
Egilman D, Roberts M. "Re: Controlled use of asbestos." International Journal of Occupational and Environmental Health, vol. 10, no. 1, 2004, pp. 99-103. |
Jacobson MF, Sharpe VA, Angell M, Ashford NA, Blum A, Chary LK, Cho M, Coull BC, Davis D, Doolittle RF, Egilman D, Epstein SS, Greenberg M, Hooper K, Huff J, Joshi TK, Krimsky S, LaDou J, Levenstein C, Miles S, Needleman H, Pellegrino ED, Ravanesi B, Sass J, Schecter A, Schneiderman JS, Schubert D, Soffritti M, Suzuki D, Takaro TK, Temple NJ, Terracini B, Thompson A, Wallinga D, Wing S. "Editorial policies on financial disclosure." Nature Neuroscience, vol. 6, no. 10, 2003, pp. 1001. |
Egilman D, Fehnel C, Bohme SR. "Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies." American Journal of Industrial Medicine, vol. 44, no. 5, 2003, pp. 540-57. |
Egilman DS, Ehrle LH. "Handling conflicts of interest between industry and academia." JAMA, vol. 289, no. 24, 2003, pp. 3240; author reply 3240-1. |
Egilman D, Kim J, Biklen M. "Proving causation: the use and abuse of medical and scientific evidence inside the courtroom--an epidemiologist's critique of the judicial interpretation of the Daubert ruling." Food and drug law journal, vol. 58, no. 2, 2003, pp. 223-50. |
Axelson O, Balbus JM, Cohen G, Davis D, Donnay A, Doolittle R, Duran BM, Egilman D, Epstein SS, Goldman L, Grandjean P, Hansen ES, Heltne P, Huff J, Infante P, Jacobson MF, Joshi TK, LaDou J, Landrigan PJ, Lee PR, Lockwood AH, MacGregor G, Melnick R, Messing K, Needleman H, Ozonoff D, Ravanesi B, Richter ED, Sass J, Schubert D, Suzuki D, Teitelbaum D, Temple NJ, Terracini B, Thompson A, Tickner J, Tomatis L, Upton AC, Whyatt RM, Wigmore D, Wilson T, Wing SB, Sharpe VA. "Re: Regulatory Toxicology and Pharmacology." International Journal of Occupational and Environmental Health, vol. 9, no. 4, 2003, pp. 386-9; author reply 389-90. |
Egilman DS, Bagley S, Biklen M, Golub AS, Bohme SR. "The beryllium "double standard" standard." International Journal of Health Services, vol. 33, no. 4, 2003, pp. 769-812. |
Egilman D, Bagley S, Connolly S. "Anything but beryllium: the beryllium industry's corruption of safety information." American Journal of Industrial Medicine, vol. 42, no. 3, 2002, pp. 270-1. |
Egilman D. "Asbestos screenings." American Journal of Industrial Medicine, vol. 42, no. 2, 2002, pp. 163. |
Ludwig ER, Madeksho L, Egilman D. "RE: Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am. J. Ind. Med. 2000. 37:275-282." American Journal of Industrial Medicine, vol. 39, no. 5, 2001, pp. 524-7. |
Egilman DS, Reinert A. "Corruption of previously published asbestos research." Archives of environmental health, vol. 55, no. 1, 2000, pp. 75-6. |
Egilman D. "Researchers should talk to workers." American Journal of Industrial Medicine, vol. 37, no. 6, 2000, pp. 668. |
Egilman DS, Walta M. "Breast implant verdicts resulted from corporate misconduct and legitimate science." American Journal of Public Health, vol. 89, no. 11, 1999, pp. 1763-4. |
Egilman D, Wallace W, Stubbs C, Mora-Corrasco F. "A little too much of the Buchenwald touch? Military radiation research at the University of Cincinnati, 1960-1972." Accountability in research, vol. 6, no. 1-2, 1998, pp. 63-102. |
Egilman D, Wallace W, Hom C. "Corporate corruption of medical literature: asbestos studies concealed by W.R. Grace & Co." Accountability in research, vol. 6, no. 1-2, 1998, pp. 127-47. |
Egilman DS, Hom CM. "Corruption of the medical literature: a second visit." American Journal of Industrial Medicine, vol. 34, no. 4, 1998, pp. 401-4; discussion 409-10. |
Egilman D, Wallace W, Stubbs C, Mora-Corrasco F. "Ethical aerobics: ACHRE's flight from responsibility." Accountability in research, vol. 6, no. 1-2, 1998, pp. 15-61. |
Egilman DS, Stubbs C. "Evaluating the health risks of breast implants." New England Journal of Medicine, vol. 335, no. 15, 1996, pp. 1154-5; author reply 1156. |
Egilman D, Punnett L, Hjelm EW, Welch L. "Evidence for work-related musculoskeletal disorders." Journal of Occupational and Environmental Medicine, vol. 38, no. 11, 1996, pp. 1079-80; author reply 1083-4. |
Egilman D, Reinert A. "Lung cancer and asbestos exposure: asbestosis is not necessary." American Journal of Industrial Medicine, vol. 30, no. 4, 1996, pp. 398-406. |
Egilman DS, Goldin AS, Goldin GA. "Mesothelioma: An unwarranted causal model." Journal of Occupational and Environmental Medicine, vol. 38, no. 3, 1996, pp. 239-40. |
Schnorr TM, Steenland K, Egeland GM, Boeniger M, Egilman D. "Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry." Occupational and environmental medicine, vol. 53, no. 10, 1996, pp. 703-7. |
Egilman D, Reinert A. "The asbestos TLV: early evidence of inadequacy." American Journal of Industrial Medicine, vol. 30, no. 3, 1996, pp. 369-70. |
Egilman DS, Reinert AA. "The origin and development of the asbestos Threshold Limit Value: scientific indifference and corporate influence." International Journal of Health Services, vol. 25, no. 4, 1995, pp. 667-96. |
Egilman DS. "Public health and epistemology." American Journal of Industrial Medicine, vol. 22, no. 3, 1992, pp. 457-9. |
Hardy H, Egilman D. "Corruption of occupational medical literature: the asbestos example." American Journal of Industrial Medicine, vol. 20, no. 1, 1991, pp. 127-9. |
Egilman D. "Ethics of mandatory masturbation." Journal of occupational medicine. : official publication of the Industrial Medical Association, vol. 30, no. 12, 1988, pp. 992-3. |
Egilman D, Greer DS. "International health needs." International Journal of Dermatology, vol. 26, no. 6, 1987, pp. 351-3. |
Greer DS, Egilman D. "International exchange for medical training." New England Journal of Medicine, vol. 314, no. 10, 1986, pp. 652. |
Frumkin H, Egilman D, Kelly M, Christiani D, Pepper L, Cone J, Sprince N, Himmelstein J. "Asbestos-related diseases." JAMA, vol. 254, no. 10, 1985, pp. 1307-9. |
Kelly RM, Egilman D, Gordon J. "Long-term health effects following isocyanate exposure." Journal of occupational medicine. : official publication of the Industrial Medical Association, vol. 27, no. 7, 1985, pp. 469-70. |
Egilman D, Lichty P. "Costs and benefits of hepatitis prophylaxis." JAMA, vol. 251, no. 21, 1984, pp. 2794. |
Year | Degree | Institution |
---|---|---|
1982 | MPH | Harvard University |
1978 | MD | Brown University |
1974 | BS | Brown University |
ENVS 1552 - Science and Power: The Corruption of Environmental Health |
PHP 1050 - Science and Power - The Corruption of Public Health |